Latest Ipratropium Bromide Stories
RIDGEFIELD, Conn., Nov. 3, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S.
- First results of the pivotal Phase 3 INPULSIS(TM) trials investigating the efficacy and safety of nintedanib, an investigational compound, in the treatment of idiopathic pulmonary fibrosis (IPF)
WASHINGTON, Sept. 17 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today advised consumers not to use certain respiratory medications purchased after Sept.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.